Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease

被引:42
作者
Dubey, Sunil Kumar [1 ]
Ram, Munnangi Siva [1 ]
Krishna, Kowthavarapu Venkata [1 ]
Saha, Ranendra Narayan [2 ]
Singhvi, Gautam [1 ]
Agrawal, Mukta [3 ]
Ajazuddin [3 ]
Saraf, Swarnlata [4 ]
Saraf, Shailendra [4 ,5 ]
Alexander, Amit [3 ]
机构
[1] BITS PILANI, Dept Pharm, Pilani Campus, Pilani, Rajasthan, India
[2] BITS PILANI, Dept Biotechnol, Dubai Campus, Dubai, U Arab Emirates
[3] Rungta Coll Pharmaceut Sci & Res, Dept Pharmaceut, Kurud Rd, Bhilai 490024, Chhattisgarh, India
[4] Pt Ravishankar Shukla Univ, Univ Inst Pharm, Raipur 492010, Chhattisgarh, India
[5] Hemchand Yadav Univ, Durg 491001, Chhattisgarh, India
关键词
Alzheimer's disease; In vitro cell line; BCECs; HBMEC; SK-N-MC; BLOOD-BRAIN-BARRIER; MICROVASCULAR ENDOTHELIAL-CELLS; AMYLOID PRECURSOR PROTEIN; PLURIPOTENT STEM-CELLS; SH-SY5Y NEUROBLASTOMA-CELLS; GAMMA-SECRETASE CLEAVAGE; IN-VITRO MODEL; N-MC CELLS; A-BETA; OXIDATIVE STRESS;
D O I
10.1007/s10571-019-00653-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Globally, the central nervous system (CNS) disordersappear as the most critical pathological threat with no proper cure. Alzheimer's disease (AD) is one such condition frequently observed with the aged population and sometimes in youth too. Most of the research utilizes different animal models for in vivo study of AD pathophysiology and to investigate the potency of the newly developed therapy. These in vivo models undoubtably provide a powerful investigation tool to study human brain. Although, it sometime fails to mimic the exact environment and responses as the human brain owing to the distinctive genetic and anatomical features of human and rodent brain. In such condition, the in vitro cell model derived from patient specific cell or human cell lines can recapitulate the human brain environment. In addition, the frequent use of animals in research increases the cost of study and creates various ethical issues. Instead, the use of in vitro cellular models along with animal models can enhance the translational values of in vivo models and represent a better and effective mean to investigate the potency of therapeutics. This strategy also limits the excessive use of laboratory animal during the drug development process. Generally, the in vitro cell lines are cultured from AD rat brain endothelial cells, the rodent models, human astrocytes, human brain capillary endothelial cells, patient derived iPSCs (induced pluripotent stem cells) and also from the non-neuronal cells. During the literature review process, we observed that there are very few reviews available which describe the significance and characteristics of in vitro cell lines, for AD investigation. Thus, in the present review article, we have compiled the various in vitro cell lines used in AD investigation including HBMEC, BCECs, SHSY-5Y, hCMEC/D3, PC-2 cell line, bEND3 cells, HEK293, hNPCs, RBE4 cells, SK-N-MC, BMVECs, CALU-3, 7W CHO, iPSCs and cerebral organoids cell lines and different types of culture media such as SCM, EMEM, DMEM/F12, RPMI, EBM and 3D-cell culture. [GRAPHICS] .
引用
收藏
页码:181 / 209
页数:29
相关论文
共 215 条
[1]   Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Chougule, Mahavir Bhupal ;
Shoyele, Sunday A. ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2018, 281 :139-177
[2]   Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Hamano, Nobuhito ;
Li, Shyh-Dar ;
Chougule, Mahavir ;
Shoyele, Sunday A. ;
Gupta, Umesh ;
Ajazuddin ;
Alexander, Amit .
EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (06) :589-617
[3]   Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease [J].
Agrawal, Mukta ;
Ajazuddin ;
Tripathi, Dulal K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Hammarlund-Udenaes, Margareta ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2017, 260 :61-77
[4]   Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium [J].
Aldick, Thomas ;
Bielaszewska, Martina ;
Zhang, Wenlan ;
Brockmeyer, Jens ;
Schmidt, Herbert ;
Friedrich, Alexander W. ;
Kim, Kwang S. ;
Schmidt, M. Alexander ;
Karch, Helge .
MICROBES AND INFECTION, 2007, 9 (03) :282-290
[5]   Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives [J].
Alexander, Amit ;
Ajazuddin ;
Patel, Ravish J. ;
Saraf, Swarnlata ;
Saraf, Shailendra .
JOURNAL OF CONTROLLED RELEASE, 2016, 241 :110-124
[6]   Understanding the Role of Poloxamer 407 based Thermoreversible In Situ Gelling Hydrogel for Delivery of PEGylated Melphalan Conjugate [J].
Alexander, Amit ;
Saraf, Swarnlata ;
Saraf, Shailendra .
CURRENT DRUG DELIVERY, 2016, 13 (04) :621-630
[7]   Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications [J].
Alexander, Amit ;
Ajazuddin ;
Khan, Junaid ;
Saraf, Swarnlata ;
Saraf, Shailendra .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 88 (03) :575-585
[8]   Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate [J].
Alexander, Amit ;
Ajazuddin ;
Khan, Junaid ;
Saraf, Swarnlata ;
Saraf, Shailendra .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2014, 66 (09) :1240-1250
[9]   Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessel endothelial cells (hBMECs) [J].
Alexandrov, Peter N. ;
Kruck, Theodore P. A. ;
Lukiw, Walter J. .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2015, 152 :210-213
[10]  
Alladi S, 2010, DEMENTIA INDIA REPOR